Skip to main content
logo
Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
6.37
-0.19 (-2.90%)
At close: Aug 10, 2026, 4:00 PM EDT
6.37
0.00 (0.00%)
After-hours: Aug 10, 2026, 4:20 PM EDT

Taysha Gene Therapies Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
7.479.778.3315.452.5-
Revenue Growth
3.42%17.28%-46.07%517.55%--
Gross Profit
7.479.778.3315.452.5-
Operating Income
-132.56-110.5-91.46-72.44-162.45-173.27
Net Income
-129.88-109-89.3-111.57-166.01-174.52
Earnings Per Share
-0.38-0.34-0.36-0.96-3.78-4.64
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
277.03320.22139.49144.3987.88149.1
Total Debt
66.7368.2861.359.4658.4163.09
Net Cash (Debt)
210.3251.9478.1884.9329.4786.01
Net Cash Growth
265.76%222.25%-7.94%188.16%-65.73%-65.77%
Net Cash Per Share
0.610.790.310.730.672.28

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-111.95-93.09-81.23-73.02-88.39-117.04
Capital Expenditures
-0.38-0.74-0.37-3.87-20.62-15.3
Free Cash Flow
-112.33-93.83-81.6-76.89-109.01-132.35
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%-
Operating Margin
-1774.37%-1130.65%-1097.55%-468.83%-6492.69%-
Pretax Margin
-1738.40%-1115.27%-1071.62%-722.06%-6635.25%-
Profit Margin
-1738.40%-1115.27%-1071.62%-722.06%-6635.25%-
FCF Margin
-1503.57%-960.07%-979.23%-497.62%-4356.87%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
272.72160.4242.5521.4256.40-